Short Bowel Patients Treated for Two Years with Glucagon-Like Peptide 2 (GLP-2): Compliance, Safety, and Effects on Quality of Life

Background and aims. Glucagon-like peptide 2 (GLP-2) has been shown to improve intestinal absorption in short bowel syndrome (SBS) patients in a short-term study. This study describes safety, compliance, and changes in quality of life in 11 SBS patients at baseline, week 13, 26, and 52 during two ye...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Jeppesen, P. B., Lund, P., Gottschalck, I. B., Nielsen, H. B., Holst, J. J., Mortensen, J., Poulsen, S. S., Quistorff, B., Mortensen, P. B.
Médium: Artigo
Jazyk:Inglês
Vydáno: Hindawi Publishing Corporation 2009
Témata:
Clinical Study
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2706978/
https://ncbi.nlm.nih.gov/pubmed/19590736
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2009/425759
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky